Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

In 1979, it was observed that parkinsonism could be induced by a toxin inhibiting mitochondrial respiratory complex I. This initiated the long-standing hypothesis that mitochondrial dysfunction may play a key role in the pathogenesis of Parkinson's disease (PD). This hypothesis evolved, with accumulating evidence pointing to complex I dysfunction, which could be caused by environmental or genetic factors. Attention was focused on the mitochondrial DNA, considering the occurrence of mutations, polymorphic haplogroup-specific variants, and defective mitochondrial DNA maintenance with the accumulation of multiple deletions and a reduction of copy number. Genetically determined diseases of mitochondrial DNA maintenance frequently manifest with parkinsonism, but the age-related accumulation of somatic mitochondrial DNA errors also represents a major driving mechanism for PD. Recently, the discovery of the genetic cause of rare inherited forms of PD highlighted an extremely complex homeostatic control over mitochondria, involving their dynamic fission/fusion cycle, the balancing of mitobiogenesis and mitophagy, and consequently the quality control surveillance that corrects faulty mitochondrial DNA maintenance. Many genes came into play, including the PINK1/parkin axis, but also OPA1, as pieces of the same puzzle, together with mitochondrial DNA damage, complex I deficiency and increased oxidative stress. The search for answers will drive future research to reach the understanding necessary to provide therapeutic options directed not only at limiting the clinical evolution of symptoms but also finally addressing the pathogenic mechanisms of neurodegeneration in PD.

Original languageEnglish
Pages (from-to)346-363
Number of pages18
JournalMovement Disorders
Volume32
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Mitochondrial DNA
Parkinson Disease
Maintenance
Parkinsonian Disorders
Mitochondrial Degradation
Electron Transport Complex I
Quality Control
DNA Damage
Mitochondria
Oxidative Stress
Mutation
Genes

Keywords

  • mitochondrial DNA
  • mitophagy
  • mtDNA
  • Parkinson disease
  • parkinsonism
  • quality control

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease. / Giannoccaro, Maria Pia; La Morgia, Chiara; Rizzo, Giovanni; Carelli, Valerio.

In: Movement Disorders, Vol. 32, No. 3, 01.03.2017, p. 346-363.

Research output: Contribution to journalReview article

@article{c70e1e4f1533465e8eace8b66f8f2c2b,
title = "Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease",
abstract = "In 1979, it was observed that parkinsonism could be induced by a toxin inhibiting mitochondrial respiratory complex I. This initiated the long-standing hypothesis that mitochondrial dysfunction may play a key role in the pathogenesis of Parkinson's disease (PD). This hypothesis evolved, with accumulating evidence pointing to complex I dysfunction, which could be caused by environmental or genetic factors. Attention was focused on the mitochondrial DNA, considering the occurrence of mutations, polymorphic haplogroup-specific variants, and defective mitochondrial DNA maintenance with the accumulation of multiple deletions and a reduction of copy number. Genetically determined diseases of mitochondrial DNA maintenance frequently manifest with parkinsonism, but the age-related accumulation of somatic mitochondrial DNA errors also represents a major driving mechanism for PD. Recently, the discovery of the genetic cause of rare inherited forms of PD highlighted an extremely complex homeostatic control over mitochondria, involving their dynamic fission/fusion cycle, the balancing of mitobiogenesis and mitophagy, and consequently the quality control surveillance that corrects faulty mitochondrial DNA maintenance. Many genes came into play, including the PINK1/parkin axis, but also OPA1, as pieces of the same puzzle, together with mitochondrial DNA damage, complex I deficiency and increased oxidative stress. The search for answers will drive future research to reach the understanding necessary to provide therapeutic options directed not only at limiting the clinical evolution of symptoms but also finally addressing the pathogenic mechanisms of neurodegeneration in PD.",
keywords = "mitochondrial DNA, mitophagy, mtDNA, Parkinson disease, parkinsonism, quality control",
author = "Giannoccaro, {Maria Pia} and {La Morgia}, Chiara and Giovanni Rizzo and Valerio Carelli",
note = "Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (La Morgia Chiara, Rizzo Giovanni, Carelli Valerio)",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/mds.26966",
language = "English",
volume = "32",
pages = "346--363",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

AU - Giannoccaro, Maria Pia

AU - La Morgia, Chiara

AU - Rizzo, Giovanni

AU - Carelli, Valerio

N1 - Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (La Morgia Chiara, Rizzo Giovanni, Carelli Valerio)

PY - 2017/3/1

Y1 - 2017/3/1

N2 - In 1979, it was observed that parkinsonism could be induced by a toxin inhibiting mitochondrial respiratory complex I. This initiated the long-standing hypothesis that mitochondrial dysfunction may play a key role in the pathogenesis of Parkinson's disease (PD). This hypothesis evolved, with accumulating evidence pointing to complex I dysfunction, which could be caused by environmental or genetic factors. Attention was focused on the mitochondrial DNA, considering the occurrence of mutations, polymorphic haplogroup-specific variants, and defective mitochondrial DNA maintenance with the accumulation of multiple deletions and a reduction of copy number. Genetically determined diseases of mitochondrial DNA maintenance frequently manifest with parkinsonism, but the age-related accumulation of somatic mitochondrial DNA errors also represents a major driving mechanism for PD. Recently, the discovery of the genetic cause of rare inherited forms of PD highlighted an extremely complex homeostatic control over mitochondria, involving their dynamic fission/fusion cycle, the balancing of mitobiogenesis and mitophagy, and consequently the quality control surveillance that corrects faulty mitochondrial DNA maintenance. Many genes came into play, including the PINK1/parkin axis, but also OPA1, as pieces of the same puzzle, together with mitochondrial DNA damage, complex I deficiency and increased oxidative stress. The search for answers will drive future research to reach the understanding necessary to provide therapeutic options directed not only at limiting the clinical evolution of symptoms but also finally addressing the pathogenic mechanisms of neurodegeneration in PD.

AB - In 1979, it was observed that parkinsonism could be induced by a toxin inhibiting mitochondrial respiratory complex I. This initiated the long-standing hypothesis that mitochondrial dysfunction may play a key role in the pathogenesis of Parkinson's disease (PD). This hypothesis evolved, with accumulating evidence pointing to complex I dysfunction, which could be caused by environmental or genetic factors. Attention was focused on the mitochondrial DNA, considering the occurrence of mutations, polymorphic haplogroup-specific variants, and defective mitochondrial DNA maintenance with the accumulation of multiple deletions and a reduction of copy number. Genetically determined diseases of mitochondrial DNA maintenance frequently manifest with parkinsonism, but the age-related accumulation of somatic mitochondrial DNA errors also represents a major driving mechanism for PD. Recently, the discovery of the genetic cause of rare inherited forms of PD highlighted an extremely complex homeostatic control over mitochondria, involving their dynamic fission/fusion cycle, the balancing of mitobiogenesis and mitophagy, and consequently the quality control surveillance that corrects faulty mitochondrial DNA maintenance. Many genes came into play, including the PINK1/parkin axis, but also OPA1, as pieces of the same puzzle, together with mitochondrial DNA damage, complex I deficiency and increased oxidative stress. The search for answers will drive future research to reach the understanding necessary to provide therapeutic options directed not only at limiting the clinical evolution of symptoms but also finally addressing the pathogenic mechanisms of neurodegeneration in PD.

KW - mitochondrial DNA

KW - mitophagy

KW - mtDNA

KW - Parkinson disease

KW - parkinsonism

KW - quality control

UR - http://www.scopus.com/inward/record.url?scp=85014118305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014118305&partnerID=8YFLogxK

U2 - 10.1002/mds.26966

DO - 10.1002/mds.26966

M3 - Review article

C2 - 28251677

AN - SCOPUS:85014118305

VL - 32

SP - 346

EP - 363

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 3

ER -